Objective To evaluate association between biomarkers and outcomes in COVID-19
hospitalised patients. COVID-19 pandemic has been a challenge. Biomarkers have always …

The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome
coronavirus 2 presents with a spectrum of clinical manifestations from asymptomatic or mild …

Background COVID-19 is a new infectious disease, for which there is currently no treatment.
It is therefore necessary to explore biomarkers to determine the extent of lung lesions and …

Background Data for predicting severity of patients with COVID-19 infection are sparse and
still under investigation. We retrospectively studied whether the admission serum C-reactive …

Respiratory infected by COVID-19 represents a major global health problem at moment
even after recovery from virus corona. Since, the lung lesions for infected patients are still …

IL-6 is usually described as a pleiotropic cytokine produced in response to tissue injury or
infection. As a pro-inflammatory cytokine, IL-6 activates innate and adaptative immune …

Aim The aim of the present study was to describe the clinical presentation of patients aged≥
80 years with coronavirus disease 2019 (COVID‐19), and provide insights regarding the …

Abstract Background Coronavirus disease-2019 (COVID-19) is a global pandemic and high
mortality rate among severe or critical COVID-19 is linked with SARS-CoV-2 infection …

Background Our aim was to evaluate the benefits and harms of adjunctive corticosteroids in
adults hospitalized with community-acquired pneumonia (CAP) using individual patient data …

Respiratory virus infection can cause severe illnesses capable of inducing acute respiratory
failure that can progress rapidly to acute respiratory distress syndrome (ARDS). ARDS is …